Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
South Korea
· Delayed Price · Currency is KRW 78,800
-1,000 (-1.25%)
At close: Mar 28, 2025, 3:30 PM KST
KRX:185750 Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Net Income | 109,073 | 212,521 | 80,953 | 42,720 | 91,633 | Upgrade
|
| Depreciation & Amortization | 39,772 | 37,030 | 33,598 | 27,482 | 23,786 | Upgrade
|
| Loss (Gain) From Sale of Assets | -154 | -111.88 | -54.05 | -119.34 | -68.18 | Upgrade
|
| Asset Writedown & Restructuring Costs | 985.36 | 199.79 | 4,008 | - | -98.94 | Upgrade
|
| Loss (Gain) From Sale of Investments | 2,764 | -1,465 | 2,772 | 98.87 | -517.38 | Upgrade
|
| Loss (Gain) on Equity Investments | - | -798.36 | 460.38 | 603.47 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 637.26 | 133.39 | 996.56 | -533.19 | 800.02 | Upgrade
|
| Other Operating Activities | -12,190 | 40,969 | 22,300 | 10,345 | 32,926 | Upgrade
|
| Change in Accounts Receivable | 3,509 | -20,947 | -45,316 | -18,267 | -10,264 | Upgrade
|
| Change in Inventory | -114,342 | -5,980 | -54,466 | -53,771 | -46,240 | Upgrade
|
| Change in Accounts Payable | 14,410 | 38,584 | 15,824 | -15,598 | 42,358 | Upgrade
|
| Change in Unearned Revenue | 18.55 | 1.14 | 0.16 | - | -1,099 | Upgrade
|
| Change in Other Net Operating Assets | 19,806 | 18,024 | 6,658 | 19,942 | -28,892 | Upgrade
|
| Operating Cash Flow | 64,289 | 318,160 | 67,734 | 12,904 | 104,324 | Upgrade
|
| Operating Cash Flow Growth | -79.79% | 369.72% | 424.92% | -87.63% | 34.98% | Upgrade
|
| Capital Expenditures | -38,474 | -41,218 | -44,898 | -48,243 | -32,639 | Upgrade
|
| Sale of Property, Plant & Equipment | 243.25 | 451.58 | 142.13 | 142.41 | 68.31 | Upgrade
|
| Sale (Purchase) of Intangibles | -27,483 | -27,588 | -8,166 | -3,591 | -4,178 | Upgrade
|
| Investment in Securities | 69,268 | -102,998 | -12,806 | -39,332 | -27,440 | Upgrade
|
| Other Investing Activities | 175.55 | 39.75 | 347.81 | 213.96 | 268.6 | Upgrade
|
| Investing Cash Flow | 3,731 | -171,313 | -65,380 | -90,809 | -63,921 | Upgrade
|
| Long-Term Debt Issued | 100,000 | 32,000 | - | 101,596 | 83,226 | Upgrade
|
| Long-Term Debt Repaid | -133,743 | -58,050 | -3,213 | -3,714 | -64,802 | Upgrade
|
| Net Debt Issued (Repaid) | -33,743 | -26,050 | -3,213 | 97,883 | 18,424 | Upgrade
|
| Repurchase of Common Stock | -16,008 | -6,025 | -1,888 | -1,935 | -2,078 | Upgrade
|
| Dividends Paid | -13,331 | -11,609 | -11,239 | -10,808 | -9,277 | Upgrade
|
| Other Financing Activities | -29.7 | -16.53 | - | -0 | - | Upgrade
|
| Financing Cash Flow | -63,112 | -43,700 | -16,340 | 85,139 | 7,069 | Upgrade
|
| Foreign Exchange Rate Adjustments | 3,915 | -917.57 | -410.12 | 920.1 | -734.87 | Upgrade
|
| Net Cash Flow | 8,824 | 102,229 | -14,396 | 8,154 | 46,737 | Upgrade
|
| Free Cash Flow | 25,815 | 276,942 | 22,836 | -35,339 | 71,684 | Upgrade
|
| Free Cash Flow Growth | -90.68% | 1112.74% | - | - | 29.27% | Upgrade
|
| Free Cash Flow Margin | 1.63% | 16.59% | 1.53% | -2.63% | 5.50% | Upgrade
|
| Free Cash Flow Per Share | 1948.91 | 19821.04 | 1696.38 | -2578.75 | 5192.55 | Upgrade
|
| Cash Interest Paid | 7,655 | 8,631 | 6,444 | 3,758 | 3,637 | Upgrade
|
| Cash Income Tax Paid | 34,868 | 11,812 | 15,561 | 51,688 | 18,266 | Upgrade
|
| Levered Free Cash Flow | -75,307 | 169,732 | -1,365 | -33,053 | 59,644 | Upgrade
|
| Unlevered Free Cash Flow | -70,108 | 175,526 | 2,914 | -30,534 | 62,064 | Upgrade
|
| Change in Net Working Capital | 106,087 | -53,178 | 46,310 | 65,406 | 2,364 | Upgrade
|
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.